
UHS Stock Forecast & Price Target
UHS Analyst Ratings
Bulls say
Universal Health Services Inc. reported a 21% year-over-year growth in adjusted EBITDA for its Acute Care Hospital Services segment, primarily due to robust topline growth and effective cost management, leading to a 150 basis point expansion in the same-store adjusted EBITDA margin to 15.7%. The Behavioral Health Services segment also saw positive performance, with same-store revenue growth of 5.5% and an increase in adjusted EBITDA margin by 40 basis points to 23.0%. Additionally, management expressed optimism regarding the approval of new programs in non-UHS states, which may further enhance revenue opportunities moving forward.
Bears say
Universal Health Services faces significant challenges that contribute to a negative outlook, primarily due to anticipated volume and margin headwinds that could lead to earnings being approximately 5% lower than current estimates for FY25. The company has reported a decline in critical metrics, with adjusted admissions down 1.6% and adjusted patient days decreasing by 0.3%, indicating weakened demand in its behavioral health services segment. Furthermore, despite a modest revenue growth rate of 2.5% per adjusted admission, the enterprise multiple of around 6.0x reflects trough levels consistent with last year's performance, signaling persistent market concerns over the firm’s financial stability.
This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.
UHS Analyst Forecast & Price Prediction
Start investing in UHS
Order type
Buy in
Order amount
Est. shares
0 shares